Dr. Reddy's Laboratories has received an approval for the fund infusion by way of investment in equity shares of Dr. Reddy’s Laboratories LLC, Russia, a step-down wholly-owned subsidiary, up to an amount of Rs 600 crore. The fund will be used for working capital requirements.

The Board of Directors of the Company at its meeting held on November 5, 2024, has approved the same.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.